Biotech · Private company
Sucampo AG
Track this companyFree. Adds Sucampo AG to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials5
- Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to PlaceboPHASE3 · COMPLETED · started Mar 13, 2017ClinicalTrials.gov NCT03097861 · fetched Nov 12, 2026
- Evaluation of the Safety of Lubiprostone in Pediatric Participants Aged ≥ 6 Years to < 18 Years With Functional ConstipationPHASE3 · COMPLETED · started Apr 12, 2016ClinicalTrials.gov NCT02766777 · fetched Nov 12, 2026
- Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel SyndromePHASE2 · TERMINATED · started Feb 1, 2015ClinicalTrials.gov NCT02544152 · fetched Nov 12, 2026
- Lubiprostone in Children With Functional ConstipationPHASE3 · COMPLETED · started Dec 13, 2013ClinicalTrials.gov NCT02042183 · fetched Nov 12, 2026
- Pharmacodynamic, Pharmacokinetic, and Tolerability Study of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic ConstipationPHASE3 · COMPLETED · started Oct 1, 2013ClinicalTrials.gov NCT01993875 · fetched Nov 12, 2026